CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
The impact of clinical experience on decision-making regarding the treatment and management of mild-to-moderate ulcerative colitis
Jae Hee Cheon, Kristine Paridaens, Sameer Al Awadhi, Jakob Begun, John R Fullarton, Edouard Louis, Fernando Magro, Juan Ricardo Marquez, Alexander R Moschen, Neeraj Narula, Grazyna Rydzewska, Axel U Dignass, Simon PL Travis
Intest Res. 2023;21(1):161-167.   Published online April 18, 2022
DOI: https://doi.org/10.5217/ir.2022.00006

Excel Download

The impact of clinical experience on decision-making regarding the treatment and management of mild-to-moderate ulcerative colitis
Intestinal Research. 2023;21(1):161-167   Crossref logo
Link1 Link2 Link3

Mild-to-Moderate Ulcerative Colitis (UC) Clinical Decision Support Tool
Gastroenterology. 2019;156(3):765   Crossref logo
Link1 Link2

What is the Best Possible Therapy for My Mild to Moderate Ulcerative Colitis? State-of-the-Art Therapy for Mild to Moderate Ulcerative Colitis
Inflammatory Bowel Disease. 2015;73-78   Crossref logo
Link1

Spicing up the Treatment of Mild to Moderate Ulcerative Colitis
Clinical Gastroenterology and Hepatology. 2015;13(8):1450-1452   Crossref logo
Link1 Link2

Management of Mild-to-Moderate Ulcerative Colitis: Patient Guide
Gastroenterology. 2019;156(3):766-767   Crossref logo
Link1 Link2

Treatment of mild to moderate ulcerative colitis and pouchitis
Alimentary Pharmacology & Therapeutics. 2002;16:13-19   Crossref logo
Link1 Link2 Link3

Developments in the treatment of moderate to severe ulcerative colitis: focus on adalimumab
Therapeutics and Clinical Risk Management. 2013;451   Crossref logo
Link1

Olsalazine versus mesalazine in the treatment of mild to moderate ulcerative colitis
Alimentary Pharmacology & Therapeutics. 1998;12(8):707-715   Crossref logo
Link1 Link2 Link3

Management of Mild-to-Moderate Ulcerative Colitis
Digestive Diseases. 2015;33(Suppl. 1):90-94   Crossref logo
Link1 Link2 Link3

Multinational evaluation of clinical decision-making in the treatment and management of mild-to-moderate ulcerative colitis
Scandinavian Journal of Gastroenterology. 2021;57(4):424-431   Crossref logo
Link1